Clinical Trial Update: Olmesartan Medoxomil in Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Olmesartan medoxomil for Type 2 diabetes mellitus has completed. The study examined cardiovascular disease and kidney involv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

Sponsor: Sankyo Pharma Gmbh | Conditions: Diabetes Mellitus, Type 2, Cardiovascular Disease | Phase 3 | Status: COMPLETED